Date: 22–24 September 2026
Venue: [Pharmedi Vietnam]
Booth No: K8
Fanttest cordially invites global distributors, healthcare professionals, and industry partners to visit us at Booth K8. Our experienced sales and technical teams will provide on-site product demonstrations, professional technical consultations, and tailored cooperation solutions, with the goal of creating sustainable, mutually beneficial business opportunities across the Vietnamese & ASEAN market.
Backed by our own standardized manufacturing facilities and comprehensive international regulatory certifications, Fanttest provides integrated IVD solutions designed to meet diverse market needs. Combined with our self-developed colloidal gold readers and matched reagent kits, our locally adapted testing systems effectively address key healthcare challenges in Southeast Asia, including limited access to standardized testing equipment, insufficient screening options, and regional supply chain instability.
At this exhibition, we present a well-structured product portfolio covering mature mainstream applications, essential year-round screening needs, consumer self-testing kits and newly upgraded, high-value niche solutions—fully aligned with the public health and clinical testing requirements of Vietnam.
Proven through long-term market validation, our tropical epidemic detection products maintain stable and reliable performance. Widely applied in public screening, border inspection and grassroots clinical scenarios, this mature lineup features high market recognition and continuous repurchase demand, serving as a steady revenue pillar for regional partners. Including Dengue Combo, Dengue NS1, Malaria rapid tests.
Covering multi-scenario institutional rapid diagnosis and home self-testing, our respiratory combo panels are designed for year-round use across diverse healthcare settings. Compatible with our self-developed reading devices, the series standardizes clinical detection and facilitates daily health monitoring, supporting partners’ long-term and stable market operation. Both professional 25T packs and self-test 1T packs are available.
Tailored for regional gastrointestinal infection screening needs, this product series fits grassroots clinics, community health stations and private medical institutions. With stable clinical performance and broad market coverage, it supplements partners’ product matrix and generates recurring order demand. Products include H.Pylori, FOB, TF&FOB, Norovirus/Rotavirus/Adenovirus combo tests.
Our home self-test portfolio covers fertility testing, vaginal health, prostate & sperm health, vitamin & iron nutrition detection, urinary tract infection and kidney health screening. These consumer-oriented rapid tests meet the fast-growing at-home health demand in Vietnam, opening up retail pharmacy and e-commerce channels for our partners.
Our STI and multi-drug rapid test portfolio is designed for applications in medical institutions, public security, workplace screening. Targeting underserved niche markets with relatively limited competition and high value-added potential, the series offers forward-looking global partners new opportunities for revenue growth and differentiated market positioning.
Fanttest offers comprehensive strengths as a reliable long-term partner. Supported by stable mass-production capabilities, extensive regulatory compliance across target markets, and multilingual regional customization services, we are committed to ensuring consistent global supply and facilitating smooth market entry for our partners.
As a key healthcare hub in the ASEAN region, Vietnam presents significant growth potential for the IVD market. Driven by technological innovation and localized healthcare empowerment, Fanttest is committed to strengthening tropical disease diagnostic solutions, optimizing regional supply chains, and forging long-term strategic partnerships that contribute to sustainable growth across Southeast Asia’s healthcare and IVD sectors.
